Overall survival | Disease free survival | ||||
---|---|---|---|---|---|
HR(95%CI) | P value | HR(95%CI) | P value | ||
KPS | 90-100 | 1 | 1 | ||
70-80 | 1.35(1.06-1.71) | 0.014 | 1.3(1.03-1.63) | 0.025 | |
Operation type | Open | 1 | 1 | ||
mini | 0.86(0.67-1.11) | 0.255 | 0.8(0.63-1.02) | 0.070 | |
Margin | R0 | 1 | 1 | ||
R1-2 | 1.53(1.05-2.22) | 0.028 | 1.22(0.84-1.79) | 0.294 | |
Varscular Invasion | No | 1 | 1 | ||
Yes | 1.34(1.02-1.78) | 0.037 | 1.18(0.91-1.54) | 0.220 | |
Neuro Invasion | No | 1 | 1 | ||
Yes | 1.02(0.76-1.36) | 0.903 | 1.22(0.93-1.61) | 0.153 | |
Path T stage | T1 | 1 | 1 | ||
T2 | 2.22(0.78-6.31) | 0.134 | 1.48(0.66-3.33) | 0.347 | |
T3 | 2.53(0.93-6.86) | 0.069 | 1.66(0.78-3.56) | 0.192 | |
T4a | 3.79(1.34-10.71) | 0.012 | 2.19(0.97-4.93) | 0.059 | |
T4b | 22.24(6.04-81.86) | 0.000 | 8.12(2.61-25.3) | 0.000 | |
Path N stage | N1 | ||||
N2 | 2.05(1.58-2.65) | 0.000 | 1.85(1.44-2.37) | 0.000 | |
N3 | 2.65(1.86-3.76) | 0.000 | 2.45(1.74-3.45) | 0.000 | |
Adjuvant Therapy | S + CT | ||||
S + CRT | 0.71(0.56-0.91) | 0.006 | 0.7(0.56-0.88) | 0.002 |